Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Richmond, Virginia 23284


Purpose:

This is a Phase 1, single-dose study to evaluate the pharmacokinetics of intravenous Ascorbic Acid.


Study summary:

The objectives of this study are: 1. To evaluate the single-dose pharmacokinetics of AA administered intravenously (IV). 2. To evaluate the safety and tolerability of AA administered intravenously.


Criteria:

Inclusion Criteria: - Is between the ages of 18 and 45 years, inclusive. - Has a body mass index (BMI) between 18 and 32 kg/m2. - Of sound health and has the ability to understand the requirements of the study and is willing to comply with all study requirements and procedures. Exclusion Criteria: - Participates in activities that would not allow accurate evaluation of the pharmacokinetics of Ascorbic Acid - Medical or physical conditions that would not allow safe participation and/or accurate evaluation of the pharmacokinetics of Ascorbic Acid - Has participated in an investigational drug study within the 30 days prior to CRU admission.


NCT ID:

NCT02534753


Primary Contact:

Study Director
Damon P Jones, BS/MBA
McGuff Pharmaceuticals, Inc.


Backup Contact:

N/A


Location Contact:

Richmond, Virginia 23284
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: November 18, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.